Privia Health Group Inc (PRVA)vsR1 RCM Inc (RCM)
PRVA
Privia Health Group Inc
$20.54
-2.33%
HEALTHCARE · Cap: $2.60B
RCM
R1 RCM Inc
$14.31
0.00%
HEALTHCARE · Cap: $6.04B
Smart Verdict
WallStSmart Research — data-driven comparison
R1 RCM Inc generates 16% more annual revenue ($2.46B vs $2.12B). PRVA leads profitability with a 108.0% profit margin vs -2.5%. PRVA earns a higher WallStSmart Score of 48/100 (D+).
PRVA
Hold48
out of 100
Grade: D+
RCM
Hold39
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-156.5%
Fair Value
$8.42
Current Price
$20.54
$12.12 premium
Intrinsic value data unavailable for RCM.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Keeps 108 of every $100 in revenue as profit
Earnings expanding 132.8% YoY
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
17.4% revenue growth
Reasonable price relative to book value
Areas to Watch
ROE of 4.0% — below average capital efficiency
Operating margin of 2.1%
Premium valuation, high expectations priced in
Expensive relative to growth rate
Operating margin of 3.8%
ROE of -2.2% — below average capital efficiency
Earnings declined 99.3%
Comparative Analysis Report
WallStSmart ResearchBull Case : PRVA
The strongest argument for PRVA centers on Profit Margin, EPS Growth, Debt/Equity. Profitability is solid with margins at 108.0% and operating margin at 2.1%. Revenue growth of 17.4% demonstrates continued momentum.
Bull Case : RCM
The strongest argument for RCM centers on Price/Book. Revenue growth of 14.7% demonstrates continued momentum.
Bear Case : PRVA
The primary concerns for PRVA are Return on Equity, Operating Margin, P/E Ratio. A P/E of 116.8x leaves little room for execution misses.
Bear Case : RCM
The primary concerns for RCM are PEG Ratio, Operating Margin, Return on Equity.
Key Dynamics to Monitor
PRVA profiles as a growth stock while RCM is a turnaround play — different risk/reward profiles.
RCM carries more volatility with a beta of 0.84 — expect wider price swings.
PRVA is growing revenue faster at 17.4% — sustainability is the question.
PRVA generates stronger free cash flow (126M), providing more financial flexibility.
Bottom Line
PRVA scores higher overall (48/100 vs 39/100), backed by strong 108.0% margins and 17.4% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Privia Health Group Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Privia Health Group, Inc. is a population health technology and medical practice management company in the United States.
Visit Website →R1 RCM Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
R1 RCM Inc (RCM) is a leading provider of technology-enabled revenue cycle management services, specializing in optimizing the financial performance of healthcare organizations. By leveraging advanced analytics and industry expertise, R1 RCM delivers comprehensive solutions that streamline patient billing processes and enhance operational efficiencies across a diverse portfolio of clients, including hospitals and outpatient facilities. The company's innovative approach not only improves revenue capture but also elevates the patient experience, positioning R1 RCM as a key player in the evolving healthcare landscape. With a robust growth strategy focused on expanding its service offerings and market reach, R1 RCM is poised to capitalize on the increasing demand for effective revenue cycle solutions in the healthcare sector.
Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?